DexCom, Inc. (DXCM)
91.04
-1.30
(-1.41%)
USD |
NASDAQ |
Aug 24, 16:00
91.52
+0.48
(+0.53%)
After-Hours: 20:00
DexCom Profit Margin (Quarterly) : 19.04% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.04% |
| March 31, 2026 | 16.74% |
| December 31, 2025 | 21.22% |
| September 30, 2025 | 23.47% |
| June 30, 2025 | 15.54% |
| March 31, 2025 | 10.17% |
| December 31, 2024 | 13.62% |
| September 30, 2024 | 13.54% |
| June 30, 2024 | 14.29% |
| March 31, 2024 | 15.90% |
| December 31, 2023 | 24.78% |
| September 30, 2023 | 12.38% |
| June 30, 2023 | 13.30% |
| March 31, 2023 | 6.55% |
| December 31, 2022 | 11.26% |
| September 30, 2022 | 13.15% |
| June 30, 2022 | 7.31% |
| March 31, 2022 | 15.47% |
| December 31, 2021 | -0.76% |
| September 30, 2021 | 13.43% |
| June 30, 2021 | 13.17% |
| March 31, 2021 | 11.19% |
| December 31, 2020 | 62.44% |
| September 30, 2020 | 14.41% |
| June 30, 2020 | 10.25% |
| Date | Value |
|---|---|
| March 31, 2020 | 4.91% |
| December 31, 2019 | 20.03% |
| September 30, 2019 | 11.56% |
| June 30, 2019 | -3.12% |
| March 31, 2019 | -9.59% |
| December 31, 2018 | -53.17% |
| September 30, 2018 | 17.47% |
| June 30, 2018 | 12.45% |
| March 31, 2018 | -13.12% |
| December 31, 2017 | -4.25% |
| September 30, 2017 | -1.08% |
| June 30, 2017 | 1.70% |
| March 31, 2017 | -29.30% |
| December 31, 2016 | -4.32% |
| September 30, 2016 | -12.65% |
| June 30, 2016 | -14.71% |
| March 31, 2016 | -16.52% |
| December 31, 2015 | 1.15% |
| September 30, 2015 | -40.40% |
| June 30, 2015 | -3.97% |
| March 31, 2015 | -17.72% |
| December 31, 2014 | 1.54% |
| September 30, 2014 | -7.54% |
| June 30, 2014 | -10.20% |
| March 31, 2014 | -26.54% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 7.37% |
| Insulet Corp. | 11.85% |
| Baxter International, Inc. | 4.56% |
| Globus Medical, Inc. | 19.20% |
| Stryker Corp. | 19.37% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 36.69% |
| Return on Assets | 14.59% |
| Return on Invested Capital | 21.78% |
| Gross Profit Margin (Quarterly) | 63.44% |
| Operating Margin (Quarterly) | 24.33% |
| Return on Net Operating Assets | 27.51% |